Summary
SynDevRx Inc
Founded in 2007
Description
SynDevRx is a leader in the growing field of Metabo-Oncology, illuminating the link between cancer and metabolic hormone dysfunction to find effective therapies.
Strengths
- Revenue generated per employee is greater than industry average
- Revenue growth is more steady than the industry average
Weaknesses
- SynDevRx Inc has a very small market share in their industry
- Revenue growth is less than the industry average
- The number of employees is not growing as fast as the industry average
- Since SynDevRx Inc was founded, the company has experienced slower revenue growth than the industry average
Annual Revenue
SynDevRx Inc's annual revenue
$2191000
Based on Kona Equity data
-
Revenue per employee
$273875
-
Variance of revenue growth
0.14
-
Annual revenue growth since founding
$128882
-
Revenue growth rate from first known quarter to current
-77.1%
Employee Count
8 employees
-
Employee growth rate from first known quarter to current
-76.7%
Executives
Joanne Schindler
Vice President, Clinical Development
j**@syndevrx.comBenjamin Mayes
Director, Process Development
b**@syndevrx.comNeal Salomon
Chief Medical Officer, Consulting & Medical Monitor
n**@syndevrx.comPierre Dufour
Senior Director, Data Analytics
p**@syndevrx.comJames Shanahan
Co-Founder & Chief Business Officer
j**@syndevrx.comPeter Cornelius
Senior Director, Translational Research
p**@syndevrx.comDavid Browning
Project Management Senior Director, Clinical Operations
d**@syndevrx.comG Score - 2
The G Score is an eight-point scale where firms are given a score of 1 for each of the criteria that they pass. The G score compares a company against the industry median to find those that are healthy and growing.
- G2 Income per employee more than industry average.
- G5 Variance of revenue growth is less than the industry average
Location
Unlock unlimited leads
Similar Companies
Novoclinica
novoclinica.com- Founded in 2006
- Location: San Francisco, CA
- Annual Revenue: $4.2M
- Employees: 21
- Novoclinica, Inc. is a clinical research organization driven by vision For Better Medicine. We provide solutions for phase I-IV clinical trials in Russian and CIS markets.
NapaJen Pharma Inc
napajen.com- Founded in 2022
- Location: Burlingame, CA
- Annual Revenue: $4.9M
- Employees: 20
- Napajen Pharma, Inc. is a clinical stage biopharmaceutical company that specializes in developing novel therapeutics using its proprietary immune cell targeted oligonucleotide delivery technology. Their technology platform allows for efficient and sele...
Brenus Pharma
brenus-pharma.com- Location: Lyon, Auvergne-Rhne-Alpes
- Annual Revenue: $2.1M
- Employees: 9
- Brenus Pharma is a French private start-up in biotechnology based in Lyon. Their mission is to fight relapsing diseases in cold solid tumors, which is currently the biggest unmet need in oncology. They have developed an allogeneic platform technology c...
Cao Pharmaceuticals
caopharmaceuticals.com- Founded in 2014
- Location: Webster, TX
- Annual Revenue: $2.2M
- Employees: 10
- Cao Pharmaceuticals is an early clinical stage oncology drug development company with a rich and deep history. We are committed to develop highly effective drugs with low and manageable toxicity for various cancers. And within much shorter timeframes compared to traditional chemotherapy development. Cao Pharmaceutical…
Arog Pharmaceuticals
arogpharma.com- Founded in 2010
- Location: Plano, TX
- Annual Revenue: $3.2M
- Employees: 15
- AROG Pharmaceuticals is a privately held, late stage biopharmaceutical company based in Dallas, Texas. We are focused on developing treatments for people with rare cancers. Our mission is to bring cures for cancers with a high unmet need. We collaborat...
FLAG Therapeutics
flagtherapeutics.com- Founded in 2013
- Location: Raleigh, NC
- Annual Revenue: $1.4M
- Employees: 5
- FLAG Therapeutics is a near term clinical stage company focused on developing new small molecule therapeutics for difficult to treat cancers. FLAG 003, the companys lead candidate for the treatment of glioblastoma multiform (GBM) and Diffuse Intrinsic...
Key Information
- Name: SynDevRx Inc
- Industry: Pharmaceutical Company
- SIC: 2834; 283
- NAICS: 32541; 325
See similar companies
-
By City Cambridge Small Pharmaceutical Company in Cambridge Mid-size Pharmaceutical Company in Cambridge
-
By State MA Small companies in MA Small Pharmaceutical Company in MA Mid-size Pharmaceutical Company in MA
-
By Industry Pharmaceutical Company Small Pharmaceutical Company Mid-size Pharmaceutical Company
-
Firmographic data G Score of 2 Founded in 2007 SIC: 2834 SIC: 283 NAICS: 32541 NAICS: 325 #Pharmaceuticals #Healthcare #Biotechnology #Drug Manufacturing & Research
Frequently Asked Questions
SynDevRx Inc's headquarters are located at 1 Broadway # 14 Cambridge, MA 02142.
SynDevRx Inc's official website is syndevrx.com
SynDevRx Inc's annual revenue is $2.2 M.
SynDevRx Inc's SIC: 2834; 283
SynDevRx Inc's NAICS: 32541; 325.
SynDevRx Inc has 8 employees
